SER
Serina Therapeutics Inc
2.10$
-2.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -505.8% | -447.6% | -572.7% | -588.0% | -14,475.9% | -65.0% | -415.1% | -78.5% | -30,601.8% | -13,811.5% | |
| 50.7% | 48.6% | 38.3% | 55.0% | 2,324.1% | 1.0% | 12.3% | 2.9% | 346.4% | 56.2% | |
| – | – | – | – | – | 2.4% | 1.4% | 0.8% | 4,633.9% | 2,917.7% | |
| 78.5% | 55.3% | 15.1% | -23.7% | -481.5% | -21.8% | -2.4% | 2.6% | -5,921.4% | 1,130.8% | |
| 1.4% | 0.1% | 135.6% | 37.1% | 37.0% | 3.1% | 1.9% | 16.0% | 39.3% | 45.4% | |
| -1.7% | 0.4% | 95.1% | -20.9% | -37.0% | 23.8% | 196.2% | -16.0% | -39.3% | -45.4% | |
| – | – | – | – | – | – | 0.0% | – | 17,857.1% | 9,614.6% | |
| – | – | – | – | – | -0.4% | 261.5% | 318.8% | 5,133.9% | 3,779.2% | |
| 435.4% | 945.5% | 429.8% | 362.6% | 11,038.9% | 31.1% | 262.4% | 319.3% | 23,592.9% | 13,393.8% | |
| -72.1% | 506.8% | -47.9% | -252.0% | -3,379.6% | -10.1% | 43.5% | 224.8% | -7,048.2% | -473.8% | |
| -507.2% | -447.7% | -708.3% | -625.1% | -14,513.0% | -68.1% | -417.1% | -94.5% | -30,641.1% | -13,811.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.